Ting Zhou
PEOPLE

Ting Zhou

Associate
zhou.ting@dorsey.com
New York P +1 (212) 415-9373 F +1 (646) 417-7259

Overview

Ting is an associate in Dorsey’s Corporate Group. Ting helps clients achieve their business goals through mergers and acquisitions, private equity and advice on corporate governance.  
Before joining Dorsey, Ting practiced in China in a leading Chinese law firm for more than 7 years. Ting’s clients have included both Chinese entities and American entities, and she is fluent in English and Mandarin.

Education & Admissions

Columbia Law School (LL.M., 2015), James Kent Scholar

East China University of Politics and Law (LL.B., 2005)

Admissions

  • New York

Languages

  • English, Mandarin

Experience

Representative Experience

  • Represented Eddingpharm Group, a leading pharmaceutical contract sales company in China, in connection with its acquisition of certain pharmaceutical product rights in China from Eli Lilly
  • Represented Yili Group, the largest dairy products company in Asia, in its bidding for Stonyfield, the No. 1 organic yogurt maker in the United States, a subsidiary of Danone
  • Representing CDH Investments, a top Chinese PE firm, in connection with multiple acquisitions and investments
  • Representing a Hong Kong Stock Exchange listed real estate conglomerate in connection with its acquisitions of multiple real estate portfolios in the United States, including retirement living facilities, student housing projects and other commercial and mixed use properties
  • Represented certain shareholders of a Minnesota-based private marketing and sales company in the proposed sale of their controlling interests in the company to a Chinese public company
  • Represented Fantasia Group, the largest Chinese property management conglomerate, in its U.S. real estate joint venture deals
  • Represented a leading non-profit biomedical research organization in the United States in connection with its proposed joint venture and collaborative research initiatives with business partners and universities in China
  • Represented a U.S. maritime technology company in its sale to a Beijing-based Chinese public company
  • Represented a family office in its investments in multiple single-investment SPV funds organized to invest in China based pre-IPO, growth-stage companies
  • Represented a Chinese state-owned asset management company (with AUM of over RMB one trillion yuan) in its investment in a $650 million private debt fund
  • Represented a private equity fund (with AUM of $250 million) in its reorganization
  • Represented a leading infrastructure construction company in China in its U.S. expansion
  • Represented Johnson Controls in selling its China related automotive electronics business (a part of its global sales of automotive electronics business) to Visteon
  • Represented a US leading auto components manufacturer, in selling part of its equity interest in a joint venture to its Chinese partner
  • Represented a major multinational medical device manufacturer in the acquisition of its distributor
  • Represented a leading Chinese ore processing company in its joint venture with a major Dutch company and a major US company
  • Represented HSBC and other underwriters for Citic Pacific (00267.HK)’ s USD 4.5 billion Euro Medium Term Notes (EMTN) Program and its updates
  • Represented China Lodging Group, Limited (NASDAQ:HTHT), a leading economy hotel chain operator in China, on its listing on NASDAQ and its annual filing
Ting Zhou